title: [Minimally invasive radical prostatectomy: Contribution of robotic support, functional and oncological outcomes].
abstract: OBJECTIVE
  Radical prostatectomy (RP) remains a standard for localized prostate cancer treatment. The objective of this study is to present this operating technique of the robot-assisted radical prostatectomy (PR-RA) and to evaluate oncological and functional results as well as on the surgical safety.
  
  
  METHODS
  A first series of 1679 patients consecutively operated in our institution with this technique from 2005 to 2010 and with a 5-year follow-up evaluated in 2014. The oncology monitoring is ensured with a PSA test every six months during the first three years and once a year the years after if the level remains undetectable.
  
  
  RESULTS
  The oncologic outcomes show 17.4% for pT2 stages and 36.9% for pT3 stages positive margins. The level of biological recurrence is 21.27% with an average delay of 88 months as the time needed for the recurrence to occur. At 12 months, urinary continence (0-1pad/day) returned at 94% of all patients and potency with successful penetration for all men is 61.1% and 88.8% for men with sexual activity before surgery.
  
  
  CONCLUSIONS
  The technique PRRA seems to be a reliable technique whose functional results studied from meta-analysis seem to be superior in terms of rapidity of recovery of the continence and erection in comparison with classical surgical or laparoscopic approach.
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France; CLCC, institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: j.hoepffner@bordeaux.unicancer.fr.
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Hoepffner
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France; CLCC, institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Gaston
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France.
authors.forename: Camille
authors.initials: C
authors.lastname: Mugnier
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France.
authors.forename: Denis
authors.initials: D
authors.lastname: Rey
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Lopez
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France; CLCC, institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France.
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Roche
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Riviere
authors.affiliation: Clinique Saint-Augustin, 114, avenue d'Arès, 33074 Bordeaux cedex, France; CLCC, institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France.
authors.forename: Pierre-Thierry
authors.initials: PT
authors.lastname: Piechaud
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D008297:Male; D000072662:Margins of Excision; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010410:Penile Erection; D011183:Postoperative Complications; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000601:surgery*; D065287:Robotic Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000209:etiology
chemical_list: D017430:Prostate-Specific Antigen
keywords: Continence; Erection; Oncological outcomes; Prostatectomie radicale robot-assistée; Robot-assisted radical prostatectomy; Résultats oncologiques; Érection